{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:49:06Z","timestamp":1790952546661,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Boston University School of Social Work"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recovery from addiction is frequently equated with abstinence. However, some individuals who resolve an addiction continue to use substances, including via substitution (i.e., increased use of one substance after eliminating\/ reducing another). Substitution may play a distinct role during early recovery (\u2264\u20091 year), as this period is marked by dramatic change and adjustment. Cannabis is one of the most used substances and is legal for medical and recreational use in an increasing number of states. Consequently, cannabis an increasingly accessible substitute for substances, like fentanyl, heroin, cocaine and methamphetamine, with higher risk profiles (e.g., associated with risk for withdrawal, overdose, and incarceration).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fourteen participants reported that they had resolved a primary opioid or stimulant addiction and subsequently increased their cannabis use within the previous 12 months. Using grounded theory, the interviewer explored their experiences of cannabis use during early recovery. Data were analyzed in three stages: line by line coding for all text related to cannabis use and recovery, focused coding, and axial coding to generate a theory about recovery with cannabis substitution. The motivational model of substance use provided sensitizing concepts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results &amp; discussion<\/jats:title>\n                <jats:p>The final sample included eight men and six women ranging in age from 20 to 50 years old. Three participants resolved an addiction to methamphetamine and the remaining 11, an addiction to opioids. Participants explained that cannabis was appealing because of its less harmful profile (e.g., no overdose risk, safe supply, few side effects). Participants\u2019 primary motives for cannabis use included mitigation of psychiatric symptoms, withdrawal\/ cravings, and boredom. While cannabis was effective toward these ends, participants also reported some negative side effects (e.g., decreased productivity, social anxiety). All participants described typical benefits of recovery (e.g., improved self-concept, better relationships) while continuing to use cannabis. Their experiences with and beliefs about substitution suggest it can be an effective strategy for some individuals during early recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Cannabis use may benefit some adults who are reducing their opioid or stimulant use, especially during early recovery. The addiction field\u2019s focus on abstinence has limited our knowledge about non-abstinent recovery. Longitudinal studies are needed to understand the nature of substitution and its impact on recovery over time.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-024-01002-0","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T07:02:08Z","timestamp":1713596528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["\u201cEverything is kind of the same except my mind is with me\u201d: exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction"],"prefix":"10.1186","volume":"21","author":[{"given":"Corinne A.","family":"Beaugard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"issue":"5","key":"1002_CR1","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s11469-020-00239-7","volume":"19","author":"M Bartram","year":"2021","unstructured":"Bartram M. It\u2019s really about wellbeing\u2019: a Canadian investigation of harm reduction as a bridge between mental health and addiction recovery. Int J Ment Health Addict. 2021;19(5):1497\u2013510.","journal-title":"Int J Ment Health Addict"},{"key":"1002_CR2","doi-asserted-by":"publisher","first-page":"102110","DOI":"10.1016\/j.cpr.2021.102110","volume":"91","author":"CE Paquette","year":"2022","unstructured":"Paquette CE, Daughters SB, Witkiewitz K. Expanding the continuum of substance use disorder treatment: nonabstinence approaches. Clin Psychol Rev. 2022;91:102110.","journal-title":"Clin Psychol Rev"},{"key":"1002_CR3","unstructured":"Substance Abuse and Mental Health Services Administration. SAMHSA\u2019s working definition of recovery: 10 guiding principles of recovery. [Internet]. 2012 [cited 2023 Jun 1]. https:\/\/store.samhsa.gov\/sites\/default\/files\/d7\/priv\/pep12-recdef.pdf."},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.cpr.2021.102083","volume":"89","author":"HS Kim","year":"2021","unstructured":"Kim HS, Hodgins DC, Garcia X, Ritchie EV, Musani I, McGrath DS, et al. A systematic review of addiction substitution in recovery: clinical lore or empirically-based? Clin Psychol Rev. 2021;89:102083.","journal-title":"Clin Psychol Rev"},{"issue":"5","key":"1002_CR5","doi-asserted-by":"publisher","first-page":"e0233463","DOI":"10.1371\/journal.pone.0233463","volume":"15","author":"S Lake","year":"2020","unstructured":"Lake S, Nosova E, Buxton J, Walsh Z, Soc\u00edas ME, Hayashi K, et al. Characterizing motivations for cannabis use in a cohort of people who use illicit drugs: a latent class analysis. PLoS ONE. 2020;15(5):e0233463.","journal-title":"PLoS ONE"},{"issue":"1","key":"1002_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12954-019-0278-6","volume":"16","author":"P Lucas","year":"2019","unstructured":"Lucas P, Baron EP, Jikomes N. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances: results from a cross-sectional survey of authorized patients. Harm Reduct J. 2019;16(1):9.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1002_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7517-6-35","volume":"6","author":"A Reiman","year":"2009","unstructured":"Reiman A. Cannabis as a substitute for alcohol and other drugs. Harm Reduct J. 2009;6(1):35.","journal-title":"Harm Reduct J"},{"key":"1002_CR8","doi-asserted-by":"publisher","first-page":"e9461","DOI":"10.7717\/peerj.9461","volume":"8","author":"B Shapira","year":"2020","unstructured":"Shapira B, Rosca P, Berkovitz R, Gorjaltsan I, Neumark Y. The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. PeerJ. 2020;8:e9461.","journal-title":"PeerJ"},{"issue":"5","key":"1002_CR9","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s11469-020-00244-w","volume":"19","author":"J Siklos-Whillans","year":"2021","unstructured":"Siklos-Whillans J, Bacchus A, Manwell LA. A scoping review of the use of cannabis and its extracts as potential harm reduction strategies: insights from preclinical and clinical research. Int J Ment Health Addict. 2021;19(5):1527\u201350.","journal-title":"Int J Ment Health Addict"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.addbeh.2017.04.006","volume":"72","author":"ME Soc\u00edas","year":"2017","unstructured":"Soc\u00edas ME, Kerr T, Wood E, Dong H, Lake S, Hayashi K, et al. Intentional cannabis use to reduce crack cocaine use in a Canadian setting: a longitudinal analysis. Addict Behav. 2017;72:138\u201343.","journal-title":"Addict Behav"},{"issue":"1","key":"1002_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12954-017-0145-2","volume":"14","author":"LM Boucher","year":"2017","unstructured":"Boucher LM, Marshall Z, Martin A, Larose-H\u00e9bert K, Flynn JV, Lalonde C, et al. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs. Harm Reduct J. 2017;14(1):18.","journal-title":"Harm Reduct J"},{"key":"1002_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.drugalcdep.2015.02.009","volume":"149","author":"LR Pacek","year":"2015","unstructured":"Pacek LR, Mauro PM, Martins SS. Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race\/ethnicity. Drug Alcohol Depend. 2015;149:232\u201344.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1002_CR13","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/00952990.2019.1669626","volume":"45","author":"R Smart","year":"2019","unstructured":"Smart R, Pacula RL. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019;45(6):644\u201363.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"1002_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1089\/can.2021.0229","volume":"8","author":"J Mok","year":"2023","unstructured":"Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, et al. Use of Cannabis as a harm reduction strategy among people who use drugs: a cohort study. Cannabis Cannabinoid Res. 2023;8(4):670\u20138.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugalcdep.2014.06.006","volume":"142","author":"M Mojarrad","year":"2014","unstructured":"Mojarrad M, Samet JH, Cheng DM, Winter MR, Saitz R. Marijuana use and achievement of abstinence from alcohol and other drugs among people with substance dependence: a prospective cohort study. Drug Alcohol Depend. 2014;142:91\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"1002_CR16","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1176\/appi.ajp.162.8.1507","volume":"162","author":"E Aharonovich","year":"2005","unstructured":"Aharonovich E, Liu X, Samet S, Nunes E, Waxman R, Hasin D. Postdischarge Cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am J Psychiatry. 2005;162(8):1507\u201314.","journal-title":"Am J Psychiatry"},{"issue":"3\u20134","key":"1002_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/19371918.2013.774663","volume":"28","author":"DM Donovan","year":"2013","unstructured":"Donovan DM, Ingalsbe MH, Benbow J, Daley DC. 12-Step interventions and mutual support programs for substance use disorders: an overview. Soc Work Public Health. 2013;28(3\u20134):313\u201332.","journal-title":"Soc Work Public Health"},{"key":"1002_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2015.06.021","volume":"154","author":"LA Kaskutas","year":"2015","unstructured":"Kaskutas LA, Witbrodt J, Grella CE. Recovery definitions: do they change? Drug Alcohol Depend. 2015;154:85\u201392.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"1002_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/09687637.2020.1779182","volume":"27","author":"TF Martinelli","year":"2020","unstructured":"Martinelli TF, Nagelhout GE, Bellaert L, Best D, Vanderplasschen W, van de Mheen D. Comparing three stages of addiction recovery: long-term recovery and its relation to housing problems, crime, occupation situation, and substance use. Drugs Educ Prev Policy. 2020;27(5):387\u201396.","journal-title":"Drugs Educ Prev Policy"},{"issue":"1","key":"1002_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/acer.14235","volume":"44","author":"K Witkiewitz","year":"2020","unstructured":"Witkiewitz K, Tucker JA. Abstinence not required: expanding the definition of recovery from Alcohol Use Disorder. Alcohol Clin Exp Res. 2020;44(1):36\u201340.","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"1002_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jsat.2007.06.001","volume":"33","author":"Betty Ford Institute Consensus Panel","year":"2007","unstructured":"Betty Ford Institute Consensus Panel. What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat. 2007;33(3):221\u20138.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"1002_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1037\/adb0000386","volume":"32","author":"JF Kelly","year":"2018","unstructured":"Kelly JF, Abry AW, Milligan CM, Bergman BG, Hoeppner BB. On being in recovery: a national study of prevalence and correlates of adopting or not adopting a recovery identity among individuals resolving drug and alcohol problems. Psychol Addict Behav. 2018;32(6):595\u2013604.","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"1002_CR23","first-page":"44","volume":"6","author":"AB Laudet","year":"2011","unstructured":"Laudet AB. The case for considering quality of life in addiction research and clinical practice. Addict Sci Clin Pract. 2011;6(1):44\u201355.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"1002_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/07347324.2013.747313","volume":"31","author":"ST Shumway","year":"2013","unstructured":"Shumway ST, Bradshaw SD, Harris KS, Baker AK. Important factors of early addiction recovery and inpatient treatment. Alcohol Treat Q. 2013;31(1):3\u201324.","journal-title":"Alcohol Treat Q"},{"key":"1002_CR25","unstructured":"Charmaz K. Constructing grounded theory. 2nd edition. London; Thousand Oaks, Calif: Sage; 2014. 388 p. (Introducing qualitative methods)."},{"issue":"7","key":"1002_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.addbeh.2012.03.016","volume":"37","author":"ZW Adams","year":"2012","unstructured":"Adams ZW, Kaiser AJ, Lynam DR, Charnigo RJ, Milich R. Drinking motives as mediators of the impulsivity-substance use relation: pathways for negative urgency, lack of premeditation, and sensation seeking. Addict Behav. 2012;37(7):848\u201355.","journal-title":"Addict Behav"},{"issue":"5","key":"1002_CR27","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.addbeh.2013.01.021","volume":"38","author":"KM Gilson","year":"2013","unstructured":"Gilson KM, Bryant C, Bei B, Komiti A, Jackson H, Judd F. Validation of the drinking motives Questionnaire (DMQ) in older adults. Addict Behav. 2013;38(5):2196\u2013202.","journal-title":"Addict Behav"},{"issue":"2","key":"1002_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1037\/a0015006","volume":"23","author":"VV Grant","year":"2009","unstructured":"Grant VV, Stewart SH, Mohr CD. Coping-anxiety and coping-depression motives predict different daily mood-drinking relationships. Psychol Addict Behav. 2009;23(2):226\u201337.","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"1002_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1077800419879081","volume":"26","author":"K Charmaz","year":"2020","unstructured":"Charmaz K. With constructivist grounded theory you can\u2019t hide: Social Justice research and critical inquiry in the public sphere. Qual Inq. 2020;26(2):165\u201376.","journal-title":"Qual Inq"},{"key":"1002_CR30","doi-asserted-by":"publisher","unstructured":"Cooper ML, Kuntsche E, Levitt A, Barber LL, Wolf S. Motivational models of substance use: A review of theory and research on motives for using alcohol, marijuana, and tobacco. In: Sher KJ, editor. The Oxford Handbook of Substance Use and Substance Use Disorders: Volume 1 [Internet]. Oxford University Press; 2016 [cited 2023 Oct 2]. p. 0. https:\/\/doi.org\/10.1093\/oxfordhb\/9780199381678.013.017.","DOI":"10.1093\/oxfordhb\/9780199381678.013.017"},{"issue":"3","key":"1002_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/14780887.2020.1780357","volume":"18","author":"K Charmaz","year":"2021","unstructured":"Charmaz K, Thornberg R. The pursuit of quality in grounded theory. Qual Res Psychol. 2021;18(3):305\u201327.","journal-title":"Qual Res Psychol"},{"key":"1002_CR32","doi-asserted-by":"publisher","first-page":"104113","DOI":"10.1016\/j.drugpo.2023.104113","volume":"119","author":"H Reddon","year":"2023","unstructured":"Reddon H, Lake S, Socias ME, Hayashi K, DeBeck K, Walsh Z, et al. Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis. Int J Drug Policy. 2023;119:104113.","journal-title":"Int J Drug Policy"},{"issue":"9","key":"1002_CR33","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.neubiorev.2012.06.006","volume":"36","author":"A Baldacchino","year":"2012","unstructured":"Baldacchino A, Balfour DJK, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 2012;36(9):2056\u201368.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"1002_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/09595230801923702","volume":"27","author":"S Darke","year":"2008","unstructured":"Darke S, Kaye S, McKETIN R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253\u201362.","journal-title":"Drug Alcohol Rev"},{"key":"1002_CR35","doi-asserted-by":"crossref","unstructured":"van Holst RJ, Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev 4(1):42\u201356.","DOI":"10.2174\/1874473711104010042"},{"key":"1002_CR36","doi-asserted-by":"crossref","unstructured":"Mattson CL. Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep [Internet]. 2021 [cited 2023 Oct 2];70. https:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7006a4.htm.","DOI":"10.15585\/mmwr.mm7006a4"},{"issue":"1","key":"1002_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/npp.2017.198","volume":"43","author":"DS Hasin","year":"2018","unstructured":"Hasin DS. US Epidemiology of Cannabis Use and Associated problems. Neuropsychopharmacology. 2018;43(1):195\u2013212.","journal-title":"Neuropsychopharmacology"},{"key":"1002_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.copsyc.2020.07.005","volume":"38","author":"E Kroon","year":"2021","unstructured":"Kroon E, Kuhns L, Cousijn J. The short-term and long-term effects of cannabis on cognition: recent advances in the field. Curr Opin Psychol. 2021;38:49\u201355.","journal-title":"Curr Opin Psychol"},{"issue":"5","key":"1002_CR39","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/add.15253","volume":"116","author":"TP Freeman","year":"2021","unstructured":"Freeman TP, Craft S, Wilson J, Stylianou S, ElSohly M, Di Forti M, et al. Changes in delta-9\u2010tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta\u2010analysis. Addiction. 2021;116(5):1000\u201310.","journal-title":"Addiction"},{"key":"1002_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.drugalcdep.2018.11.012","volume":"195","author":"BJ Arterberry","year":"2019","unstructured":"Arterberry BJ, Treloar Padovano H, Foster KT, Zucker RA, Hicks BM. Higher average potency across the United States is associated with progression to first cannabis use disorder symptom. Drug Alcohol Depend. 2019;195:186\u201392.","journal-title":"Drug Alcohol Depend"},{"issue":"15","key":"1002_CR41","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1017\/S0033291715001178","volume":"45","author":"TP Freeman","year":"2015","unstructured":"Freeman TP, Winstock AR. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med. 2015;45(15):3181\u20139.","journal-title":"Psychol Med"},{"issue":"1","key":"1002_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/09595239996734","volume":"18","author":"D Best","year":"1999","unstructured":"Best D, Gossop M, Greenwood J, Marsden J, Lehmann P, Strang J. Cannabis use in relation to illicit drug use and health problems among opiate misusers in treatment. Drug Alcohol Rev. 1999;18(1):31\u20138.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"1002_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12954-021-00468-6","volume":"18","author":"T Rosic","year":"2021","unstructured":"Rosic T, Kapoor R, Panesar B, Naji L, Chai DB, Sanger N, et al. The association between cannabis use and outcome in pharmacological treatment for opioid use disorder. Harm Reduct J. 2021;18(1):24.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1002_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s42238-022-00135-y","volume":"4","author":"A Asselin","year":"2022","unstructured":"Asselin A, Lamarre OB, Chamberland R, McNeil SJ, Demers E, Zongo A. A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada. J Cannabis Res. 2022;4(1):26.","journal-title":"J Cannabis Res"},{"issue":"9","key":"1002_CR45","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/da.22771","volume":"35","author":"S Turner","year":"2018","unstructured":"Turner S, Mota N, Bolton J, Sareen J. Self-medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature. Depress Anxiety. 2018;35(9):851\u201360.","journal-title":"Depress Anxiety"},{"issue":"1","key":"1002_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/YCO.0000000000000566","volume":"33","author":"M van Ameringen","year":"2020","unstructured":"van Ameringen M, Zhang J, Patterson B, Turna J. The role of cannabis in treating anxiety: an update. Curr Opin Psychiatry. 2020;33(1):1.","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"1002_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/10550887.2020.1856298","volume":"39","author":"H Bonny-Noach","year":"2021","unstructured":"Bonny-Noach H, Gold D. Addictive behaviors and craving during the COVID-19 pandemic of people who have recovered from substance use disorder. J Addict Dis. 2021;39(2):257\u201364.","journal-title":"J Addict Dis"},{"issue":"2","key":"1002_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/02791072.2008.10400627","volume":"40","author":"MS Levy","year":"2008","unstructured":"Levy MS. Listening to our clients: the prevention of relapse. J Psychoact Drugs. 2008;40(2):167\u201372.","journal-title":"J Psychoact Drugs"},{"issue":"2","key":"1002_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cpr.2005.11.002","volume":"26","author":"JR McKay","year":"2006","unstructured":"McKay JR, Franklin TR, Patapis N, Lynch KG. Conceptual, methodological, and analytical issues in the study of relapse. Clin Psychol Rev. 2006;26(2):109\u201327.","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"1002_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1521\/jscp.2009.28.3.307","volume":"28","author":"SA Fahlman","year":"2009","unstructured":"Fahlman SA, Mercer KB, Gaskovski P, Eastwood AE, Eastwood JD. Does a lack of life meaning cause boredom? Results from psychometric, longitudinal, and experimental analyses. J Soc Clin Psychol. 2009;28(3):307\u201340.","journal-title":"J Soc Clin Psychol"},{"issue":"2","key":"1002_CR51","first-page":"15","volume":"8","author":"N LaPera","year":"2011","unstructured":"LaPera N. Relationships between boredom proneness, mindfulness, anxiety, depression, and substance use. New Sch Psychol Bull. 2011;8(2):15\u201325.","journal-title":"New Sch Psychol Bull"},{"issue":"6","key":"1002_CR52","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0193841X07307771","volume":"31","author":"ML Dennis","year":"2007","unstructured":"Dennis ML, Foss MA, Scott CK. An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Eval Rev. 2007;31(6):585\u2013612.","journal-title":"Eval Rev"},{"issue":"3","key":"1002_CR53","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/10550887.2012.694604","volume":"31","author":"AB Laudet","year":"2012","unstructured":"Laudet AB. Rate and predictors of employment among formerly polysubstance dependent urban individuals in recovery. J Addict Dis. 2012;31(3):288\u2013302.","journal-title":"J Addict Dis"},{"issue":"4","key":"1002_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/0034355217730395","volume":"62","author":"D O\u2019Sullivan","year":"2019","unstructured":"O\u2019Sullivan D, Xiao Y, Watts JR. Recovery capital and quality of life in stable recovery from addiction. Rehabil Couns Bull. 2019;62(4):209\u201321.","journal-title":"Rehabil Couns Bull"},{"issue":"4","key":"1002_CR55","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/1533256X.2016.1235429","volume":"16","author":"MT Walton","year":"2016","unstructured":"Walton MT, Hall MT. The effects of employment interventions on addiction treatment outcomes: a review of the literature. J Soc Work Pract Addict. 2016;16(4):358\u201384.","journal-title":"J Soc Work Pract Addict"},{"key":"1002_CR56","unstructured":"Slawek D, Arnsten JH. Medical use of cannabis and cannabinoids in adults. 2023 Nov."},{"issue":"4","key":"1002_CR57","doi-asserted-by":"publisher","first-page":"405","DOI":"10.15288\/jsad.2020.81.405","volume":"81","author":"H Rosenberg","year":"2020","unstructured":"Rosenberg H, Grant J, Davis AK. Acceptance of non-abstinence as an outcome goal for individuals diagnosed with substance use disorders: a narrative review of published research. J Stud Alcohol Drugs. 2020;81(4):405\u201315.","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"1002_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/09687631003705546","volume":"18","author":"J Neale","year":"2011","unstructured":"Neale J, Nettleton S, Pickering L. Recovery from problem drug use: what can we learn from the sociologist Erving Goffman? Drugs Educ Prev Policy. 2011;18(1):3\u20139.","journal-title":"Drugs Educ Prev Policy"},{"issue":"2","key":"1002_CR59","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/01632787211012036","volume":"44","author":"S Sussman","year":"2021","unstructured":"Sussman S, Commentary. Addiction, stigma, and neurodiversity. Eval Health Prof. 2021;44(2):186\u201391.","journal-title":"Eval Health Prof"},{"issue":"4","key":"1002_CR60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/16066359.2021.2007888","volume":"30","author":"SL Proctor","year":"2022","unstructured":"Proctor SL, Lipsey J, Rigg KK. The insanity of addiction treatment in America. Addict Res Theory. 2022;30(4):231\u20136.","journal-title":"Addict Res Theory"},{"key":"1002_CR61","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1002_CR62","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01002-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01002-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01002-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T08:05:37Z","timestamp":1713600337000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01002-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01002-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]},"assertion":[{"value":"22 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Boston University Charles River Campus Institutional Review Board approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided verbal consent for participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors provided consent for this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no competing interests to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}